Aug 06, 2020 / 08:30PM GMT
Operator
Greetings, and welcome to the Ziopharm Oncology Second Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Chris Taylor, Vice President of Investor Relations and Corporate Communications.
Christopher Taylor - ZIOPHARM Oncology, Inc. - VP of IR & Corporate Communications
Thank you, operator. Good afternoon, and welcome to the Ziopharm Oncology conference call and webcast to review results for the second quarter ended June 30, 2020. This afternoon, we filed our 10-Q and issued our second quarter financial news release, both of which are available in the Investors section of our website, ziopharm.com. For informational purposes, we've also included in our webcast a set of PowerPoint slides to accompany today's commentary. These slides can also be found on our website in the Investors section.
During this call, the company will make a number of forward-looking statements, including statements regarding the potential
Q2 2020 ZIOPHARM Oncology Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot